170 related articles for article (PubMed ID: 19336517)
41. Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations.
Trancikova A; Mamais A; Webber PJ; Stafa K; Tsika E; Glauser L; West AB; Bandopadhyay R; Moore DJ
PLoS One; 2012; 7(10):e47784. PubMed ID: 23082216
[TBL] [Abstract][Full Text] [Related]
42. Phosphorylated 4E-BP1 is associated with tumor progression and adverse prognosis in colorectal cancer.
Chen Y; Wang J; Fan H; Xie J; Xu L; Zhou B
Neoplasma; 2017; 64(5):787-794. PubMed ID: 28592131
[TBL] [Abstract][Full Text] [Related]
43. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
[TBL] [Abstract][Full Text] [Related]
44. Macrophage inflammatory protein-1alpha and interferon-inducible protein 10 inhibit synergistically induced growth factor stimulation of MAP kinase activity and suppress phosphorylation of eukaryotic initiation factor 4E and 4E binding protein 1.
Aronica SM; Gingras AC; Sonenberg N; Cooper S; Hague N; Broxmeyer HE
Blood; 1997 May; 89(10):3582-95. PubMed ID: 9160663
[TBL] [Abstract][Full Text] [Related]
45. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer.
Ye Q; Cai W; Zheng Y; Evers BM; She QB
Oncogene; 2014 Apr; 33(14):1828-39. PubMed ID: 23624914
[TBL] [Abstract][Full Text] [Related]
46. Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6.
Shi Y; Hsu JH; Hu L; Gera J; Lichtenstein A
J Biol Chem; 2002 May; 277(18):15712-20. PubMed ID: 11872747
[TBL] [Abstract][Full Text] [Related]
47. Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors.
Ducker GS; Atreya CE; Simko JP; Hom YK; Matli MR; Benes CH; Hann B; Nakakura EK; Bergsland EK; Donner DB; Settleman J; Shokat KM; Warren RS
Oncogene; 2014 Mar; 33(12):1590-600. PubMed ID: 23542178
[TBL] [Abstract][Full Text] [Related]
48. Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1.
Hu J; Straub J; Xiao D; Singh SV; Yang HS; Sonenberg N; Vatsyayan J
Cancer Res; 2007 Apr; 67(8):3569-73. PubMed ID: 17440067
[TBL] [Abstract][Full Text] [Related]
49. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.
Connor JH; Lyles DS
J Virol; 2002 Oct; 76(20):10177-87. PubMed ID: 12239292
[TBL] [Abstract][Full Text] [Related]
50. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.
Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC
J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354
[TBL] [Abstract][Full Text] [Related]
51. Endotoxin (LPS) stimulates 4E-BP1/PHAS-I phosphorylation in macrophages.
Potter MW; Shah SA; Elbirt KK; Callery MP
J Surg Res; 2001 May; 97(1):54-9. PubMed ID: 11319880
[TBL] [Abstract][Full Text] [Related]
52. Eukaryotic Initiation Factor 4E phosphorylation acts a switch for its binding to 4E-BP1 and mRNA cap assembly.
Batool A; Majeed ST; Aashaq S; Majeed R; Andrabi KI
Biochem Biophys Res Commun; 2020 Jun; 527(2):489-495. PubMed ID: 32336547
[TBL] [Abstract][Full Text] [Related]
53. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function.
Schalm SS; Fingar DC; Sabatini DM; Blenis J
Curr Biol; 2003 May; 13(10):797-806. PubMed ID: 12747827
[TBL] [Abstract][Full Text] [Related]
54. BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation.
Silva JM; Bulman C; McMahon M
Mol Cancer Res; 2014 Mar; 12(3):447-63. PubMed ID: 24425783
[TBL] [Abstract][Full Text] [Related]
55. Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency.
Li S; Sonenberg N; Gingras AC; Peterson M; Avdulov S; Polunovsky VA; Bitterman PB
Mol Cell Biol; 2002 Apr; 22(8):2853-61. PubMed ID: 11909977
[TBL] [Abstract][Full Text] [Related]
56. Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling.
Kaur S; Lal L; Sassano A; Majchrzak-Kita B; Srikanth M; Baker DP; Petroulakis E; Hay N; Sonenberg N; Fish EN; Platanias LC
J Biol Chem; 2007 Jan; 282(3):1757-68. PubMed ID: 17114181
[TBL] [Abstract][Full Text] [Related]
57. Pancreatic tumours escape from translational control through 4E-BP1 loss.
Martineau Y; Azar R; Müller D; Lasfargues C; El Khawand S; Anesia R; Pelletier J; Bousquet C; Pyronnet S
Oncogene; 2014 Mar; 33(11):1367-74. PubMed ID: 23563181
[TBL] [Abstract][Full Text] [Related]
58. Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1.
Wang J; Ye Q; Cao Y; Guo Y; Huang X; Mi W; Liu S; Wang C; Yang HS; Zhou BP; Evers BM; She QB
Nat Commun; 2017 Dec; 8(1):2207. PubMed ID: 29263324
[TBL] [Abstract][Full Text] [Related]
59. PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability.
Yu L; Shang ZF; Wang J; Wang H; Huang F; Zhang Z; Wang Y; Zhou J; Li S
Oncotarget; 2015 Aug; 6(24):20356-69. PubMed ID: 26011939
[TBL] [Abstract][Full Text] [Related]
60. Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer.
Lv T; Wang Q; Cromie M; Liu H; Tang S; Song Y; Gao W
Oncotarget; 2015 Oct; 6(32):33006-18. PubMed ID: 26360779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
